|
⚲
|
| Keyboard |
| Remeditex Ventures LLC
✚
|
|
|---|---|
| CIK # | 0001627363 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001627363] | |
| 4 | [0001627363] | |
| SC 13D | [0001627363] | |
| SC 13G | [0001627363] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Remeditex Ventures LLC | Soliton Inc | [2019-04-03] |
| Remeditex Ventures LLC | Miragen Therapeutics Inc | [2017-02-17] |
| Remeditex Ventures LLC | Apollo Endosurgery Inc | [2017-01-09] |
| Remeditex Ventures LLC | Venaxis Inc | [2016-09-19] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Soliton Inc | |
| Remeditex Ventures LLC | |
| VYNE Therapeutics Inc | |
| Miragen Therapeutics Inc | |
| Lpath Inc | |
| Bellicum Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Soliton Inc SOLY
Warrant (right to buy) · derivative
|
2021-12-16 | Disposed to issuer | 250,000 | ||
|
Soliton Inc SOLY
Warrant (right to buy) · derivative
|
2021-12-16 | Disposed to issuer | 170,808 | ||
|
Soliton Inc SOLY
Common Stock
|
2021-12-16 | Disposed to issuer | 9,214,277 | $22.60 | 208,242,660 |
|
Soliton Inc SOLY
Common Stock
|
2020-06-30 | Buy | 120,481 | $8.30 | 999,992 |
|
Lpath Inc APEN
Common Stock
|
2019-12-29 | Other | 1,309,392 | ||
|
Soliton Inc SOLY
Warrant (right to buy) · derivative
|
2019-10-11 | Buy | 170,808 | ||
|
Soliton Inc SOLY
Common Stock
|
2019-10-11 | Buy | 155,280 | ||
|
Soliton Inc SOLY
Common Stock
|
2019-06-19 | Buy | 357,143 | ||
|
Soliton Inc SOLY
Warrant (right to buy) · derivative
|
2019-06-19 | Buy | 250,000 | ||
|
VYNE Therapeutics Inc MNLO
Series C Preferred Stock · derivative
|
2018-01-29 | Conversion | 821,596 | $0.00 | |
|
VYNE Therapeutics Inc MNLO
Series B Preferred Stock · derivative
|
2018-01-29 | Conversion | 2,351,097 | $0.00 | |
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2018-01-29 | Conversion | 2,650 | ||
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2018-01-29 | Conversion | 871,583 | ||
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2018-01-29 | Conversion | 304,576 | ||
|
VYNE Therapeutics Inc MNLO
Series A Preferred Stock · derivative
|
2018-01-29 | Conversion | 7,150 | $0.00 | |
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2018-01-25 | Buy | 100,000 | $17.00 | 1,700,000 |
|
Bellicum Pharmaceuticals Inc BLCM
Common Stock
|
2014-12-23 | Conversion | 159,444 | ||
|
Bellicum Pharmaceuticals Inc BLCM
Common Stock
|
2014-12-23 | Conversion | 1,359,297 | ||
|
Bellicum Pharmaceuticals Inc BLCM
Series C Convertible Preferred Stock · derivative
|
2014-12-23 | Conversion | 271,055 | $0.00 | |
|
Bellicum Pharmaceuticals Inc BLCM
Series C Convertible Preferred Stock · derivative
|
2014-12-23 | Conversion | 417,009 | $0.00 | |
| showing 20 of 25 most recent transactions | |||||